TY  - JOUR
AU  - Burgaz García-Oteyza, Sonia
AU  - García García, María Concepción
AU  - Gómez Cañas, María
AU  - Muñoz, Eduardo
AU  - Fernández Ruiz, Javier
PY  - 2019
DO  - 10.3390/molecules24152702
SN  - 1420-3049
UR  - https://hdl.handle.net/20.500.14352/12579
T2  - Molecules
AB  - In a recent study, we described the neuroprotective properties of VCE-003.2—an aminoquinone derivative of the non-psychotropic phytocannabinoid cannabigerol (CBG)—administered intraperitoneally (i.p.) in an inflammatory model of Parkinson’s disease...
LA  - eng
M2  - 2702
PB  - MDPI
KW  - cannabinoids
KW  - VCE-003.2
KW  - oral formulation
KW  - PPAR-γ
KW  - γ receptors
KW  - inflammation
KW  - Parkinson’s disease
TI  - Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson’s Disease
TY  - journal article
VL  - 24
ER  -